Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Evolva Holding SA    EVE   CH0021218067

EVOLVA HOLDING SA

(EVE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

EQS-Adhoc: Evolva shareholders approve all proposed resolutions at the Annual General Meeting 2021

04/08/2021 | 06:18pm BST
EQS Group-Ad-hoc: Evolva Holding SA / Key word(s): Miscellaneous 
Evolva shareholders approve all proposed resolutions at the Annual General Meeting 2021 
08-Apr-2021 / 19:15 CET/CEST 
Release of an ad hoc announcement pursuant to Art. 53 KR 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Reinach, April 8, 2021 - Evolva shareholders approved all proposals put forward by the Board of Directors at Evolva's 
Annual General Meeting (AGM). In accordance with the Swiss COVID-19 Ordinance 3, the 2021 AGM was held without 
shareholders being physically present. Accordingly, shareholders exercised their shareholder rights via the Independent 
Proxy. 
Increase of the Authorized Capital 
Shareholders approved the increase of Authorized Capital in the maximum amount of CHF 2,968,782.35 (respectively 
maximum of 59,375,647 registered shares) by CHF 4,634,391.20 to the new maximum amount of CHF 7,603,173.55 
(respectively maximum of 152,063,471 registered shares). 
Elections of the Chairman and of the Board of Directors 
Shareholders re-elected Beat In-Albon as Chairman of the Board of Directors as well as Richard Ridinger and Stephan 
Schindler as members of the Board of Directors, for a one year period. 
In addition, Christoph Breucker was elected as new member of the Board of Directors. 
Election of the Compensation Committee 
Shareholders elected Richard Ridinger, Stephan Schindler and Christoph Breucker as members of the Compensation 
Committee. 
Election of the Auditors 
The Shareholders elected Mazars Ltd., Zurich, as auditors for a term of one year. 
For a detailed listing of all resolutions at the 2021 Annual General Meeting, please visit: evolva.com/shareholder-info 
/annual-general-meeting-of-shareholders/. 
About Evolva 
Evolva is a Swiss biotech company focused on the research, development and commercialization of ingredients based on 
nature. We have leading businesses in Flavors and Fragrances, Health Ingredients and Health Protection. Evolva's 
employees, half of which are women, are dedicated to make the best products that can contribute to health, wellbeing 
and sensory enjoyment. Find out more at evolva.com. 
For Evolva multi media content, please visit: evolva.com/multimedia-library/. 
Disclaimer 
This press release contains specific forward-looking statements, e.g. statements including terms like believe assume, 
expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties 
and other factors which may result in a substantial divergence between the actual results, financial situation, 
development or performance of the company and those explicity or implicity presumed in these statements. The company 
assumes no responsibility to update forward-looking statements or to adapt them to future events or developments. 
Contact 
Barbara Duci 
Head of Investor and Corporate Relations 
+41 61 485 2003 
+41 79 739 2636 
barbarad@evolva.com 
=---------------------------------------------------------------------------------------------------------------------- 
End of ad hoc announcement 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      Evolva Holding SA 
              Duggingerstrasse 23 
              4153 Reinach 
              Switzerland 
Phone:        +41 61 485 20 00 
Internet:     www.evolva.com 
ISIN:         CH0021218067 
Valor:        2121806 
Listed:       SIX Swiss Exchange 
EQS News ID:  1182654 
 
End of Announcement EQS Group News Service 
=------------ 

1182654 08-Apr-2021 CET/CEST

(END) Dow Jones Newswires

April 08, 2021 13:17 ET (17:17 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
EVOLVA HOLDING SA -1.96% 0.2 Delayed Quote.0.99%
LONZA GROUP AG -2.19% 536.4 Delayed Quote.-3.59%
SCHINDLER HOLDING AG -0.96% 268.2 Delayed Quote.13.59%
All news about EVOLVA HOLDING SA
01:33pEVOLVA  : shareholders approve all proposed resolutions at the Annual General Me..
AQ
04/08EVOLVA  : shareholders approve all proposed resolutions at the Annual General Me..
PU
04/08EQS-ADHOC : Evolva shareholders approve all proposed resolutions at the Annual G..
DJ
04/08EVOLVA  : shareholders approve all proposed resolutions at the Annual General Me..
EQ
03/24EVOLVA  : to Appoint New CFO in Mid-April
MT
03/24EQS-ADHOC  : Evolva announces new Chief Financial Officer
DJ
03/17EVOLVA  : publishes agenda for 2021 Annual General Meeting
PU
03/16EQS-ADHOC  : Evolva publishes agenda for 2021 Annual General Meeting
DJ
03/16EVOLVA  : publishes agenda for 2021 Annual General Meeting
EQ
03/02EVOLVA  : CFO Steps Down
MT
More news
Financials
Sales 2021 13,2 M 14,2 M 10,3 M
Net income 2021 -24,3 M -26,3 M -19,1 M
Net Debt 2021 2,29 M 2,48 M 1,80 M
P/E ratio 2021 -6,92x
Yield 2021 -
Capitalization 186 M 201 M 146 M
EV / Sales 2021 14,3x
EV / Sales 2022 7,70x
Nbr of Employees 70
Free-Float 82,2%
Chart EVOLVA HOLDING SA
Duration : Period :
Evolva Holding SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVOLVA HOLDING SA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 0,29 CHF
Last Close Price 0,20 CHF
Spread / Highest target 56,9%
Spread / Average Target 39,7%
Spread / Lowest Target 22,5%
EPS Revisions
Managers and Directors
NameTitle
Oliver Walker Chief Executive & Financial Officer
Beat In-Albon Chairman
Astrid Schäfer Head-Research & Development
Gerhard Lobmaier Chief Operating Officer
Nic Buergin Secretary, Head-Legal & Compliance
Sector and Competitors
1st jan.Capitalization (M$)
EVOLVA HOLDING SA0.99%201
MODERNA, INC.34.89%56 442
LONZA GROUP AG-3.59%43 993
IQVIA HOLDINGS INC.15.90%39 822
CELLTRION, INC.-13.79%37 705
SEAGEN INC.-18.44%25 900